Bioterrorism Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Bioterrorism

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who started this subject	1/26/2004 10:09:10 AM
From: Paul Lee	of 891

CBMX running as the target has been raised 09:32 ET CBMX target raised to $10 at Brean Murray 7.60 +0.23: Brean Murray reiterates its Strong Buy on CombiMatrix and raises its target to $10 from $8. The firm believes the co's landscape has recently changed for the better, thereby leading it to reduce its 2006 EPS discount rate to 25% from 35% which results in the new target price. The 35% discount rate is no longer justified, as earlier uncertainties of Roche's launch timeline for matrixArray are no longer relevant. CBMX is now in control of the entire launch process, which should commence in March 2004.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next